CompletedNot Applicable

Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland

Egypt80 participantsStarted 2020-01-15

Plain-language summary

Thyroidectomy is the procedure by which surgeons treat various thyroid diseases and is considered the commonest endocrinal surgery. Yet, it carries a risk for intraoperative complications. The most distressing complications are recurrent laryngeal nerve and parathyroid injuries. Methylene blue spray is a technique than can be used for easy identification of both recurrent laryngeal nerve and parathyroid glands so we can avoid their injuries.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age of 16 years and older. * Both sexes. * Patients who are candidate for thyroid surgery and euthyroid. Exclusion Criteria: * \- Patients with hyper- or hypo-thyroid status. * Patients who were unfit for surgery. * Patients with unilateral or bilateral vocal cord palsy on preoperative indirect laryngoscopy * Patients with thyroid malignancy by preoperative FNAC. * Patients with hypersensitivity to methylene blue were excluded.

What they're measuring

detection of the recurrent larngeal nerve unstained

Timeframe: one minute after dye application

detection of the parathyroig glands

Timeframe: 3 minutes after dye application

Trial details

NCT IDNCT05113628

SponsorZagazig University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2021-06-10

View on ClinicalTrials.gov More Methylene Blue trials